The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors. [electronic resource]
Producer: 20190910Description: 698-706 p. digitalISSN:- 1537-6613
- Amino Acid Substitution
- Drug Resistance, Viral
- HIV -- drug effects
- HIV Infections -- drug therapy
- HIV Integrase -- genetics
- HIV Integrase Inhibitors -- therapeutic use
- Heterocyclic Compounds, 3-Ring -- therapeutic use
- Humans
- Maintenance Chemotherapy -- methods
- Microbial Sensitivity Tests
- Mutation, Missense
- Oxazines
- Piperazines
- Pyridones
- Treatment Failure
- Viral Load
- Virus Replication
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.